Maik J. Grundeken

Showing 1-20 of 22 articles

In vitro validation of coronary CT angiography for the evaluation of complex lesions

Collet C, Onuma Y, Grundeken M.J, Miyazaki Y, Bittercourt M, Kitslaar P, Motoyama S, Ozaki Y, Asano T, Wentzel J, Streekstra G.J., Serruys P, de Winter R, Planken R.N.

February 2, 2018 | 10.4244/EIJ-D-17-00326

Coronary interventions

State of the art: coronary angiography

Collet C, Grundeken M.J, Asano T, Onuma Y, Wijns W, Serruys P

August 25, 2017 | 10.4244/EIJ-D-17-00465

Coronary interventions

Clinical outcomes with the STENTYS self-apposing coronary stent in patients presenting with ST-segment elevation myocardial infarction: two-year insights from the APPOSITION III (A Post-Market registry to assess the STENTYS self-exPanding COronary Stent In AcuTe MyocardIal InfarctiON) registry

Lu H, Grundeken M.J, Vos N, IJsselmuiden A, van Geuns R, Wessely R, Dengler T, La Manna A, Silvain J, Montalescot G, Spaargaren R, Thijssen J, Amoroso G, de Winter R, Koch K

August 4, 2017 | 10.4244/EIJ-D-16-00676

Coronary interventions

Quantitative angiography methods for bifurcation lesions: a consensus statement update from the European Bifurcation Club

Collet C, Onuma Y, Cavalcante R, Grundeken M.J, Généreux P, Popma J, Costa R, Stankovic G, Tu S, Reiber J, Aben J, Flensted Lassen J, Louvard Y, Lansky A, Serruys P

May 15, 2017 | 10.4244/EIJ-D-16-00932

Coronary interventions

Comparative analysis method of permanent metallic stents (XIENCE) and bioresorbable poly-L-lactic (PLLA) scaffolds (Absorb) on optical coherence tomography at baseline and follow-up

Nakatani S, Sotomi Y, Ishibashi Y, Grundeken M.J, Tateishi H, Tenekecioglu E, Zeng Y, Suwannasom P, Regar E, Radu M, Räber L, Bezerra H, Costa M, Fitzgerald P, Prati F, Costa R, Dijkstra J, Kimura T, Kozuma K, Tanabe K, Akasaka T, Di Mario C, Serruys P, Onuma Y

December 20, 2016 | 10.4244/EIJY15M10_03

Coronary interventions

Regular drug-eluting stents versus the dedicated coronary bifurcation sirolimus-eluting BiOSS LIM® stent: the randomised, multicentre, open-label, controlled POLBOS II trial

Gil R, Bil J, Grundeken M.J, Kern A, Iñigo Garcia L, Vassilev D, Pawłowski T, Formuszewicz R, Dobrzycki S, Wykrzykowska J, Serruys P

December 9, 2016 | 10.4244/EIJY15M11_11

Coronary interventions

Long-term effectiveness and safety of the sirolimus-eluting BiOSS LIM® dedicated bifurcation stent in the treatment of distal left main stenosis: an international registry

Gil R, Bil J, Grundeken M.J, Iñigo Garcia L, Vassilev D, Kern A, Pawłowski T, Wykrzykowska J, Serruys P

November 20, 2016 | 10.4244/EIJY15M10_05

Coronary interventions

Two-year clinical outcomes of Absorb bioresorbable vascular scaffold implantation in complex coronary artery disease patients stratified by SYNTAX score and ABSORB II study enrolment criteria

Kraak R, Grundeken M.J, Hassell M, Elias J, Koch K, Henriques J, Piek J, Baan Jr J, Vis M, Thijssen J, de Winter R, Wykrzykowska J

August 5, 2016 | 10.4244/EIJV12I5A95

Coronary interventions

First-in-man evaluation of the novel balloon delivery system STENTYS Xposition S for the self-apposing coronary artery stent: impact on longitudinal geographic miss during stenting

Lu H, IJsselmuiden A, Grundeken M.J, Nassif M, de Vries A, Weevers A, Scholte M, Spaargaren R, Wykrzykowska J, Thijssen J, de Winter R, Koch K

March 18, 2016 | 10.4244/EIJY15M05_07

Treatment of coronary bifurcation lesions with the Absorb bioresorbable vascular scaffold in combination with the Tryton dedicated coronary bifurcation stent: evaluation using two- and three-dimensional optical coherence tomography

Grundeken M.J, Hassell M, Kraak R, de Bruin D, Koch K, Henriques J, van Leeuwen T, Thijssen J, Piek J, de Winter R, Wykrzykowska J

December 20, 2015 | 10.4244/EIJY14M08_15

Reversal of flow between serial bifurcation lesions: insights from computational fluid dynamic analysis in a population-based phantom model

Barlis P, Poon E, Thondapu V, Grundeken M.J, Tu S, Hayat U, Ooi A, Moore S, Tenekecioglu E, Wykrzykowska J, Serruys P

September 22, 2015 | 10.4244/EIJV11I5A111

Will this trial change my practice? The Dual Antiplatelet Therapy (DAPT) study – 12 or 30 months of dual antiplatelet therapy after drug-eluting stents

Grundeken M.J, Lansky A, Tanguay J, Gershlick A, Baumbach A, Cuisset T

July 20, 2015 | 10.4244/EIJV11I3A71

Coronary interventions

The EuroIntervention coronary bifurcation treatment supplement

Stankovic G, Flensted Lassen J, Hildick-Smith D, Lefèvre T, Louvard Y, Gwon H, Grundeken M.J

May 19, 2015 | 10.4244/EIJV11SVA2

Coronary interventions

The need for dedicated bifurcation quantitative coronary angiography (QCA) software algorithms to evaluate bifurcation lesions

Grundeken M.J, Ishibashi Y, Ramcharitar S, Tuinenburg J, Reiber J, Tu S, Aben J, Girasis C, Wykrzykowska J, Onuma Y, Serruys P

May 19, 2015 | 10.4244/EIJV11SVA10

Coronary interventions

Dedicated stents for distal left main stenting

Grundeken M.J, Magro M, Gil R, Briguori C, Sardella G, Berland J, Wykrzykowska J, Serruys P

May 19, 2015 | 10.4244/EIJV11SVA29

Coronary interventions

Is there a need for dedicated devices?

Wykrzykowska J, Grundeken M.J, Stankovic G, Di Mario C

May 19, 2015 | 10.4244/EIJV11SVA31

Coronary interventions

The Tryton Side Branch Stent

Grundeken M.J, Généreux P, Wykrzykowska J, Leon M, Serruys P

May 19, 2015 | 10.4244/EIJV11SVA33

Coronary interventions

The future of BRS in bifurcations

Kraak R, Grundeken M.J, Onuma Y, Tu S, Wykrzykowska J, Chevalier B, Ormiston J, Serruys P

May 19, 2015 | 10.4244/EIJV11SVA45

First report on free expansion simulations of a dedicated bifurcation stent mounted on a stepped balloon

Chiastra C, Grundeken M.J, Wu W, Serruys P, de Winter R, Dubini G, Wykrzykowska J, Migliavacca F

March 20, 2015 | 10.4244/EIJV10I11A226

Initial experience and clinical evaluation of the Absorb bioresorbable vascular scaffold (BVS) in real-world practice: the AMC Single Centre Real World PCI Registry

Kraak R, Hassell M, Grundeken M.J, Koch K, Henriques J, Piek J, Baan Jr J, Vis M, Arkenbout E, Thijssen J, de Winter R, Wykrzykowska J

February 20, 2015 | 10.4244/EIJY14M08_08

Latest news

NEW ISSUE

State of the Art on ViV-TAVI; Transseptal Punctures; Endovascular Closure and TF-TAVI; Percutaneous PVL Closure: Long-Term Outcomes; and more

October 20, 2021

STATE OF THE ART

Valve-in-valve TAVI: a practical overview

Giuseppe Tarantini et al.

October 20, 2021

AHEAD OF PRINT

TAVI in younger (<70 years old) patients: the AMTRAC registry

Guy Witberg et al.

October 22, 2021

AHEAD OF PRINT

Impact of LVOT calcification in transfemoral TAVI patients

L. Waldschmidt et al.

Impact of preprocedural biological markers on 10-year mortality in the SYNTAXES trial

Hironori Hara et al.

October 22, 2021

AHEAD OF PRINT

Serum caffeine causes adenosine-induced FFR overestimation

Hideaki Tanaka et al.